Foxo4-DRI
October 10, 2023Major Finding
6/10
Purrptide digest
Senescent cells — the 'zombie cells' that stop dividing but refuse to die, instead spewing inflammatory signals — are a major driver of aging. Foxo4-DRI targets only them. It disrupts a specific protein interaction that senescent cells rely on to survive, triggering their self-destruct sequence without touching healthy cells. In aged mice, it restored fur density, kidney function, and running endurance within weeks. The before/after photos in the original paper are genuinely striking.
What this means for you
🏃
If you care about weight/health
Not human-tested yet, but the selective senescent-cell-killing mechanism is exactly the kind of precision the longevity field has been chasing.
🩺
If you're a clinician
A senolytic that spares healthy cells is mechanistically distinct from broader senolytic drug candidates currently in development.
🔬
If you're a researcher
The Foxo4-p53 interaction disruption mechanism is precisely targeted — this isn't a blunt instrument, it's a scalpel.
💸
If you follow biotech
Senolytics is one of the hottest categories in longevity biotech right now. A peptide this selective is a serious contender.
BA
Baar et al.
Erasmus University Medical Center
For the nerds
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Cell · DOI: 10.1016/j.cell.2017.02.031
Read full paper on PubMed →